Clinical trial
Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.
NCT05392647 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.
- Lead sponsor
- Tongji Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 1, 2022
- Completion date
- December 31, 2024
- Enrollment
- 28 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.